Micron Biomedical

Carousel - Homepage

CEPI and Micron Biomedical Accelerate Needle-Free Vaccines against Disease X with $3.7 Million Grant to Advance Learnings from COVID-19

January 8, 2025

Micron Biomedical Secures $43 Million in Total Grant Support to Improve Coverage of Measles and Rubella Vaccine and Accelerate World’s First Phase 2 Trial of Needle-Free Drug and Vaccine Technology in Infants

January 7, 2025

Micron Biomedical Wins the “Biotech Medical Innovation” Award at Boston Biotech Week

October 17, 2024